AIDS Vaccine Discovery

The International AIDS Vaccine Initiative (IAVI) is a global non-profit scientific organization dedicated to developing vaccines and antibodies for HIV and other neglected infectious diseases. IAVI operates its own research laboratories and manages a diverse pipeline of candidates, ranging from early-stage discovery to clinical trials. The organization is particularly known for its work on broadly neutralizing antibodies (bNAbs) and its use of the Vesicular Stomatitis Virus (VSV) vector platform. By collaborating with academic, governmental, and pharmaceutical partners, IAVI aims to ensure that life-saving biomedical innovations are accessible in low-income countries.